Updated COVID-19 boosters likely to be discussed at CDC advisors meeting next week
hapabapa/iStock Editorial via Getty Images


The CDC's Advisory Committee on Immunization Practices is likely to discuss updated COVID-19 vaccines that provide protection against Omicron subvariants at a two-day meeting on Sept. 1 and 2.
In order for the advisors to discuss the shots from Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX), the US FDA would have to first grant Emergency Use Authorizations for them. A top FDA official told The New York Times on Tuesday the agency is close to making those authorizations.

Peter Marks, director of the agency's Center for Biologics Evaluation and Research, noted that a campaign to roll out the updated vaccines is slated to happen just after Labor Day.
Moderna (MRNA) and Pfizer (PFE)/BioNTech (BNTX) are expected to deliver 175M doses of updated COVID-19 vaccines for the new campaign.